id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-0308-0003,FDA,FDA-2014-E-0308,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2014-05-27T04:00:00Z,2014,5,2014-05-27T04:00:00Z,,2014-05-27T15:07:51Z,,0,0,0900006481715722
FDA-2014-E-0308-0002,FDA,FDA-2014-E-0308,"Patent Extension from McCarter & English, LLP (on behalf of Napo Pharmaceuticals, Inc.)",Other,Application,2014-03-14T04:00:00Z,2014,3,2014-03-14T04:00:00Z,,2014-03-14T13:51:39Z,,0,0,0900006481664cc1
FDA-2014-E-0308-0001,FDA,FDA-2014-E-0308,U.S. Patent and Trademark Office,Other,Letter(s),2014-03-14T04:00:00Z,2014,3,2014-03-14T04:00:00Z,,2014-03-14T13:50:50Z,,0,0,0900006481664cbf